nodes	percent_of_prediction	percent_of_DWPC	metapath
Desvenlafaxine—CYP3A4—Ticagrelor—coronary artery disease	0.079	0.146	CbGbCtD
Desvenlafaxine—CYP3A4—Fenofibrate—coronary artery disease	0.0704	0.131	CbGbCtD
Desvenlafaxine—CYP3A4—Gemfibrozil—coronary artery disease	0.0563	0.104	CbGbCtD
Desvenlafaxine—CYP3A4—Clopidogrel—coronary artery disease	0.0488	0.0905	CbGbCtD
Desvenlafaxine—CYP3A4—Eplerenone—coronary artery disease	0.0454	0.0841	CbGbCtD
Desvenlafaxine—CYP3A4—Enalapril—coronary artery disease	0.0405	0.075	CbGbCtD
Desvenlafaxine—CYP3A4—Rosuvastatin—coronary artery disease	0.0315	0.0583	CbGbCtD
Desvenlafaxine—CYP3A4—Ezetimibe—coronary artery disease	0.0315	0.0583	CbGbCtD
Desvenlafaxine—CYP3A4—Simvastatin—coronary artery disease	0.0293	0.0542	CbGbCtD
Desvenlafaxine—CYP3A4—Pravastatin—coronary artery disease	0.0286	0.053	CbGbCtD
Desvenlafaxine—CYP3A4—Lovastatin—coronary artery disease	0.0286	0.053	CbGbCtD
Desvenlafaxine—CYP3A4—Atorvastatin—coronary artery disease	0.0261	0.0483	CbGbCtD
Desvenlafaxine—CYP3A4—Losartan—coronary artery disease	0.0238	0.0442	CbGbCtD
Desvenlafaxine—Venlafaxine—CYP2C19—coronary artery disease	0.000726	1	CrCbGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—HDAC9—coronary artery disease	0.000313	0.00556	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Xenobiotics—CYP2C19—coronary artery disease	0.000309	0.0055	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—GPX2—coronary artery disease	0.000307	0.00545	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—HSPD1—coronary artery disease	0.000303	0.00539	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Tamoxifen metabolism—CYP2C19—coronary artery disease	0.000298	0.00529	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Monoamine Transport—IL1B—coronary artery disease	0.000297	0.00528	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—GSTA1—coronary artery disease	0.000296	0.00526	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—ARNTL—coronary artery disease	0.000291	0.00518	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—GPX3—coronary artery disease	0.000289	0.00514	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—ALDOA—coronary artery disease	0.000279	0.00495	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Constitutive Androstane Receptor Pathway—SULT1A1—coronary artery disease	0.000277	0.00492	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG5—coronary artery disease	0.000264	0.00469	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—UTS2—coronary artery disease	0.000264	0.00468	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—GCLC—coronary artery disease	0.000261	0.00464	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Monoamine Transport—IL1B—coronary artery disease	0.000255	0.00454	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—GPX3—coronary artery disease	0.000249	0.00442	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—TGFB2—coronary artery disease	0.000247	0.0044	CbGpPWpGaD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—HK2—coronary artery disease	0.000243	0.00433	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Aflatoxin activation and detoxification—GGT1—coronary artery disease	0.000243	0.00432	CbGpPWpGaD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC27A1—coronary artery disease	0.000233	0.00415	CbGpPWpGaD
Desvenlafaxine—Diarrhoea—Lovastatin—coronary artery disease	0.000225	0.000557	CcSEcCtD
Desvenlafaxine—Paraesthesia—Perindopril—coronary artery disease	0.000225	0.000557	CcSEcCtD
Desvenlafaxine—SLC6A2—NRF2 pathway—GCLC—coronary artery disease	0.000224	0.00399	CbGpPWpGaD
Desvenlafaxine—Decreased appetite—Captopril—coronary artery disease	0.000224	0.000555	CcSEcCtD
Desvenlafaxine—Nausea—Acetylsalicylic acid—coronary artery disease	0.000224	0.000554	CcSEcCtD
Desvenlafaxine—Malnutrition—Lisinopril—coronary artery disease	0.000223	0.000554	CcSEcCtD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—IL1RN—coronary artery disease	0.000223	0.00396	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—CST3—coronary artery disease	0.000222	0.00395	CbGpPWpGaD
Desvenlafaxine—Dizziness—Fenofibrate—coronary artery disease	0.000222	0.000551	CcSEcCtD
Desvenlafaxine—Somnolence—Perindopril—coronary artery disease	0.000222	0.000551	CcSEcCtD
Desvenlafaxine—Fatigue—Captopril—coronary artery disease	0.000222	0.000551	CcSEcCtD
Desvenlafaxine—Vertigo—Ramipril—coronary artery disease	0.000221	0.000549	CcSEcCtD
Desvenlafaxine—CYP3A4—Tryptophan metabolism—HADH—coronary artery disease	0.000221	0.00393	CbGpPWpGaD
Desvenlafaxine—Syncope—Ramipril—coronary artery disease	0.000221	0.000548	CcSEcCtD
Desvenlafaxine—Asthenia—Simvastatin—coronary artery disease	0.00022	0.000546	CcSEcCtD
Desvenlafaxine—Diarrhoea—Ezetimibe—coronary artery disease	0.00022	0.000546	CcSEcCtD
Desvenlafaxine—Constipation—Captopril—coronary artery disease	0.00022	0.000546	CcSEcCtD
Desvenlafaxine—Angioedema—Timolol—coronary artery disease	0.00022	0.000546	CcSEcCtD
Desvenlafaxine—Tension—Lisinopril—coronary artery disease	0.000219	0.000544	CcSEcCtD
Desvenlafaxine—Dysgeusia—Lisinopril—coronary artery disease	0.000219	0.000543	CcSEcCtD
Desvenlafaxine—Dizziness—Clopidogrel—coronary artery disease	0.000219	0.000542	CcSEcCtD
Desvenlafaxine—Paraesthesia—Furosemide—coronary artery disease	0.000218	0.000541	CcSEcCtD
Desvenlafaxine—Palpitations—Ramipril—coronary artery disease	0.000218	0.00054	CcSEcCtD
Desvenlafaxine—SLC6A4—NRF2 pathway—HSPA1A—coronary artery disease	0.000218	0.00387	CbGpPWpGaD
Desvenlafaxine—Decreased appetite—Perindopril—coronary artery disease	0.000217	0.000539	CcSEcCtD
Desvenlafaxine—Dizziness—Lovastatin—coronary artery disease	0.000217	0.000538	CcSEcCtD
Desvenlafaxine—Nervousness—Lisinopril—coronary artery disease	0.000217	0.000538	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Ramipril—coronary artery disease	0.000217	0.000537	CcSEcCtD
Desvenlafaxine—Vertigo—Timolol—coronary artery disease	0.000216	0.000537	CcSEcCtD
Desvenlafaxine—Somnolence—Furosemide—coronary artery disease	0.000216	0.000536	CcSEcCtD
Desvenlafaxine—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—coronary artery disease	0.000216	0.00384	CbGpPWpGaD
Desvenlafaxine—Syncope—Timolol—coronary artery disease	0.000216	0.000536	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Perindopril—coronary artery disease	0.000216	0.000535	CcSEcCtD
Desvenlafaxine—Diarrhoea—Eplerenone—coronary artery disease	0.000216	0.000535	CcSEcCtD
Desvenlafaxine—Fatigue—Perindopril—coronary artery disease	0.000216	0.000535	CcSEcCtD
Desvenlafaxine—SLC6A4—Monoamine Transport—TNF—coronary artery disease	0.000215	0.00383	CbGpPWpGaD
Desvenlafaxine—Constipation—Perindopril—coronary artery disease	0.000214	0.00053	CcSEcCtD
Desvenlafaxine—Vomiting—Fenofibrate—coronary artery disease	0.000214	0.00053	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Valsartan—coronary artery disease	0.000214	0.00053	CcSEcCtD
Desvenlafaxine—Convulsion—Ramipril—coronary artery disease	0.000214	0.000529	CcSEcCtD
Desvenlafaxine—Dizziness—Ezetimibe—coronary artery disease	0.000213	0.000528	CcSEcCtD
Desvenlafaxine—Palpitations—Timolol—coronary artery disease	0.000213	0.000528	CcSEcCtD
Desvenlafaxine—SLC6A2—NRF2 pathway—TGFB2—coronary artery disease	0.000213	0.00378	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C19—coronary artery disease	0.000212	0.00378	CbGpPWpGaD
Desvenlafaxine—Insomnia—Losartan—coronary artery disease	0.000212	0.000526	CcSEcCtD
Desvenlafaxine—Rash—Fenofibrate—coronary artery disease	0.000212	0.000526	CcSEcCtD
Desvenlafaxine—Dermatitis—Fenofibrate—coronary artery disease	0.000212	0.000525	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Timolol—coronary artery disease	0.000212	0.000525	CcSEcCtD
Desvenlafaxine—Decreased appetite—Furosemide—coronary artery disease	0.000211	0.000524	CcSEcCtD
Desvenlafaxine—Headache—Fenofibrate—coronary artery disease	0.000211	0.000522	CcSEcCtD
Desvenlafaxine—Vision blurred—Lisinopril—coronary artery disease	0.000211	0.000522	CcSEcCtD
Desvenlafaxine—Paraesthesia—Losartan—coronary artery disease	0.000211	0.000522	CcSEcCtD
Desvenlafaxine—Vomiting—Clopidogrel—coronary artery disease	0.00021	0.000521	CcSEcCtD
Desvenlafaxine—Diarrhoea—Simvastatin—coronary artery disease	0.00021	0.000521	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Furosemide—coronary artery disease	0.00021	0.00052	CcSEcCtD
Desvenlafaxine—Fatigue—Furosemide—coronary artery disease	0.00021	0.00052	CcSEcCtD
Desvenlafaxine—Tremor—Lisinopril—coronary artery disease	0.000209	0.000519	CcSEcCtD
Desvenlafaxine—CYP3A4—Estrogen metabolism—GSTM1—coronary artery disease	0.000209	0.00372	CbGpPWpGaD
Desvenlafaxine—Anxiety—Ramipril—coronary artery disease	0.000209	0.000518	CcSEcCtD
Desvenlafaxine—Vomiting—Lovastatin—coronary artery disease	0.000209	0.000518	CcSEcCtD
Desvenlafaxine—Somnolence—Losartan—coronary artery disease	0.000209	0.000517	CcSEcCtD
Desvenlafaxine—Dizziness—Eplerenone—coronary artery disease	0.000208	0.000517	CcSEcCtD
Desvenlafaxine—Rash—Clopidogrel—coronary artery disease	0.000208	0.000517	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	0.000208	0.000517	CcSEcCtD
Desvenlafaxine—Dermatitis—Clopidogrel—coronary artery disease	0.000208	0.000516	CcSEcCtD
Desvenlafaxine—Asthenia—Valsartan—coronary artery disease	0.000208	0.000516	CcSEcCtD
Desvenlafaxine—Hypertension—Timolol—coronary artery disease	0.000208	0.000516	CcSEcCtD
Desvenlafaxine—Constipation—Furosemide—coronary artery disease	0.000208	0.000515	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Niacin—coronary artery disease	0.000208	0.000515	CcSEcCtD
Desvenlafaxine—Asthenia—Olmesartan—coronary artery disease	0.000207	0.000514	CcSEcCtD
Desvenlafaxine—Headache—Clopidogrel—coronary artery disease	0.000207	0.000513	CcSEcCtD
Desvenlafaxine—Rash—Lovastatin—coronary artery disease	0.000207	0.000513	CcSEcCtD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC22A3—coronary artery disease	0.000207	0.00368	CbGpPWpGaD
Desvenlafaxine—Dermatitis—Lovastatin—coronary artery disease	0.000207	0.000513	CcSEcCtD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—ESR2—coronary artery disease	0.000206	0.00367	CbGpPWpGaD
Desvenlafaxine—Headache—Lovastatin—coronary artery disease	0.000206	0.00051	CcSEcCtD
Desvenlafaxine—Dry mouth—Ramipril—coronary artery disease	0.000205	0.000509	CcSEcCtD
Desvenlafaxine—Vomiting—Ezetimibe—coronary artery disease	0.000205	0.000508	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Pravastatin—coronary artery disease	0.000205	0.000507	CcSEcCtD
Desvenlafaxine—Anxiety—Timolol—coronary artery disease	0.000204	0.000507	CcSEcCtD
Desvenlafaxine—Angioedema—Lisinopril—coronary artery disease	0.000204	0.000506	CcSEcCtD
Desvenlafaxine—Decreased appetite—Losartan—coronary artery disease	0.000204	0.000506	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	0.000204	0.000505	CcSEcCtD
Desvenlafaxine—SLC6A4—NRF2 pathway—GGT1—coronary artery disease	0.000204	0.00362	CbGpPWpGaD
Desvenlafaxine—Dizziness—Simvastatin—coronary artery disease	0.000203	0.000504	CcSEcCtD
Desvenlafaxine—Rash—Ezetimibe—coronary artery disease	0.000203	0.000503	CcSEcCtD
Desvenlafaxine—Dermatitis—Ezetimibe—coronary artery disease	0.000203	0.000503	CcSEcCtD
Desvenlafaxine—Asthenia—Niacin—coronary artery disease	0.000202	0.000502	CcSEcCtD
Desvenlafaxine—Fatigue—Losartan—coronary artery disease	0.000202	0.000501	CcSEcCtD
Desvenlafaxine—Headache—Ezetimibe—coronary artery disease	0.000202	0.0005	CcSEcCtD
Desvenlafaxine—Vertigo—Lisinopril—coronary artery disease	0.000201	0.000498	CcSEcCtD
Desvenlafaxine—Dry mouth—Timolol—coronary artery disease	0.000201	0.000497	CcSEcCtD
Desvenlafaxine—Constipation—Losartan—coronary artery disease	0.000201	0.000497	CcSEcCtD
Desvenlafaxine—Syncope—Lisinopril—coronary artery disease	0.0002	0.000497	CcSEcCtD
Desvenlafaxine—Vomiting—Eplerenone—coronary artery disease	0.0002	0.000497	CcSEcCtD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—F7—coronary artery disease	0.0002	0.00355	CbGpPWpGaD
Desvenlafaxine—Nausea—Fenofibrate—coronary artery disease	0.0002	0.000495	CcSEcCtD
Desvenlafaxine—Asthenia—Pravastatin—coronary artery disease	0.000199	0.000494	CcSEcCtD
Desvenlafaxine—Rash—Eplerenone—coronary artery disease	0.000199	0.000493	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Trandolapril—coronary artery disease	0.000199	0.000493	CcSEcCtD
Desvenlafaxine—Dermatitis—Eplerenone—coronary artery disease	0.000199	0.000492	CcSEcCtD
Desvenlafaxine—Diarrhoea—Valsartan—coronary artery disease	0.000198	0.000492	CcSEcCtD
Desvenlafaxine—Shock—Ramipril—coronary artery disease	0.000198	0.000491	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Enalapril—coronary artery disease	0.000198	0.000491	CcSEcCtD
Desvenlafaxine—Palpitations—Lisinopril—coronary artery disease	0.000197	0.00049	CcSEcCtD
Desvenlafaxine—Diarrhoea—Olmesartan—coronary artery disease	0.000197	0.00049	CcSEcCtD
Desvenlafaxine—Headache—Eplerenone—coronary artery disease	0.000197	0.00049	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Ramipril—coronary artery disease	0.000197	0.000489	CcSEcCtD
Desvenlafaxine—Loss of consciousness—Lisinopril—coronary artery disease	0.000196	0.000487	CcSEcCtD
Desvenlafaxine—Nausea—Clopidogrel—coronary artery disease	0.000196	0.000487	CcSEcCtD
Desvenlafaxine—Tachycardia—Ramipril—coronary artery disease	0.000196	0.000487	CcSEcCtD
Desvenlafaxine—Skin disorder—Ramipril—coronary artery disease	0.000195	0.000484	CcSEcCtD
Desvenlafaxine—Vomiting—Simvastatin—coronary artery disease	0.000195	0.000484	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Telmisartan—coronary artery disease	0.000195	0.000484	CcSEcCtD
Desvenlafaxine—Nausea—Lovastatin—coronary artery disease	0.000195	0.000484	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Ramipril—coronary artery disease	0.000194	0.000482	CcSEcCtD
Desvenlafaxine—Rash—Simvastatin—coronary artery disease	0.000194	0.00048	CcSEcCtD
Desvenlafaxine—Dermatitis—Simvastatin—coronary artery disease	0.000193	0.00048	CcSEcCtD
Desvenlafaxine—Asthenia—Trandolapril—coronary artery disease	0.000193	0.00048	CcSEcCtD
Desvenlafaxine—Shock—Timolol—coronary artery disease	0.000193	0.00048	CcSEcCtD
Desvenlafaxine—Diarrhoea—Niacin—coronary artery disease	0.000193	0.000478	CcSEcCtD
Desvenlafaxine—Nervous system disorder—Timolol—coronary artery disease	0.000193	0.000478	CcSEcCtD
Desvenlafaxine—Asthenia—Enalapril—coronary artery disease	0.000193	0.000478	CcSEcCtD
Desvenlafaxine—Headache—Simvastatin—coronary artery disease	0.000192	0.000477	CcSEcCtD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—FXYD1—coronary artery disease	0.000192	0.00341	CbGpPWpGaD
Desvenlafaxine—Dizziness—Valsartan—coronary artery disease	0.000192	0.000476	CcSEcCtD
Desvenlafaxine—Nausea—Ezetimibe—coronary artery disease	0.000191	0.000474	CcSEcCtD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—HK1—coronary artery disease	0.000191	0.00339	CbGpPWpGaD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC8A1—coronary artery disease	0.000191	0.00339	CbGpPWpGaD
Desvenlafaxine—Skin disorder—Timolol—coronary artery disease	0.000191	0.000474	CcSEcCtD
Desvenlafaxine—Dizziness—Olmesartan—coronary artery disease	0.000191	0.000473	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Timolol—coronary artery disease	0.00019	0.000471	CcSEcCtD
Desvenlafaxine—Asthenia—Telmisartan—coronary artery disease	0.00019	0.000471	CcSEcCtD
Desvenlafaxine—Diarrhoea—Pravastatin—coronary artery disease	0.00019	0.000471	CcSEcCtD
Desvenlafaxine—Anxiety—Lisinopril—coronary artery disease	0.00019	0.00047	CcSEcCtD
Desvenlafaxine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	0.000189	0.000469	CcSEcCtD
Desvenlafaxine—Nausea—Eplerenone—coronary artery disease	0.000187	0.000464	CcSEcCtD
Desvenlafaxine—SLC6A2—NRF2 pathway—HSPA1A—coronary artery disease	0.000187	0.00333	CbGpPWpGaD
Desvenlafaxine—Dizziness—Niacin—coronary artery disease	0.000186	0.000462	CcSEcCtD
Desvenlafaxine—Dry mouth—Lisinopril—coronary artery disease	0.000186	0.000461	CcSEcCtD
Desvenlafaxine—SLC6A2—Monoamine Transport—TNF—coronary artery disease	0.000185	0.00329	CbGpPWpGaD
Desvenlafaxine—Asthenia—Captopril—coronary artery disease	0.000185	0.000458	CcSEcCtD
Desvenlafaxine—Diarrhoea—Trandolapril—coronary artery disease	0.000184	0.000457	CcSEcCtD
Desvenlafaxine—Vomiting—Valsartan—coronary artery disease	0.000184	0.000457	CcSEcCtD
Desvenlafaxine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11B2—coronary artery disease	0.000184	0.00327	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—GJA1—coronary artery disease	0.000184	0.00327	CbGpPWpGaD
Desvenlafaxine—Diarrhoea—Enalapril—coronary artery disease	0.000184	0.000456	CcSEcCtD
Desvenlafaxine—Dizziness—Pravastatin—coronary artery disease	0.000184	0.000455	CcSEcCtD
Desvenlafaxine—Vomiting—Olmesartan—coronary artery disease	0.000184	0.000455	CcSEcCtD
Desvenlafaxine—SLC6A4—NRF2 pathway—GSTP1—coronary artery disease	0.000183	0.00325	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—TGFBR2—coronary artery disease	0.000183	0.00325	CbGpPWpGaD
Desvenlafaxine—Rash—Valsartan—coronary artery disease	0.000183	0.000453	CcSEcCtD
Desvenlafaxine—Dermatitis—Valsartan—coronary artery disease	0.000183	0.000453	CcSEcCtD
Desvenlafaxine—Nausea—Simvastatin—coronary artery disease	0.000182	0.000452	CcSEcCtD
Desvenlafaxine—Rash—Olmesartan—coronary artery disease	0.000182	0.000451	CcSEcCtD
Desvenlafaxine—Insomnia—Ramipril—coronary artery disease	0.000182	0.000451	CcSEcCtD
Desvenlafaxine—Dermatitis—Olmesartan—coronary artery disease	0.000182	0.000451	CcSEcCtD
Desvenlafaxine—CYP3A4—Oxidation by Cytochrome P450—CYP11B2—coronary artery disease	0.000182	0.00323	CbGpPWpGaD
Desvenlafaxine—Headache—Valsartan—coronary artery disease	0.000182	0.000451	CcSEcCtD
Desvenlafaxine—Diarrhoea—Telmisartan—coronary artery disease	0.000181	0.000449	CcSEcCtD
Desvenlafaxine—Headache—Olmesartan—coronary artery disease	0.000181	0.000448	CcSEcCtD
Desvenlafaxine—Paraesthesia—Ramipril—coronary artery disease	0.000181	0.000448	CcSEcCtD
Desvenlafaxine—SLC6A4—NRF2 pathway—HMOX1—coronary artery disease	0.00018	0.00321	CbGpPWpGaD
Desvenlafaxine—Shock—Lisinopril—coronary artery disease	0.000179	0.000445	CcSEcCtD
Desvenlafaxine—Asthenia—Perindopril—coronary artery disease	0.000179	0.000445	CcSEcCtD
Desvenlafaxine—Vomiting—Niacin—coronary artery disease	0.000179	0.000445	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Furosemide—coronary artery disease	0.000179	0.000444	CcSEcCtD
Desvenlafaxine—Somnolence—Ramipril—coronary artery disease	0.000179	0.000443	CcSEcCtD
Desvenlafaxine—Dizziness—Trandolapril—coronary artery disease	0.000178	0.000442	CcSEcCtD
Desvenlafaxine—Tachycardia—Lisinopril—coronary artery disease	0.000178	0.000441	CcSEcCtD
Desvenlafaxine—Insomnia—Timolol—coronary artery disease	0.000178	0.000441	CcSEcCtD
Desvenlafaxine—Rash—Niacin—coronary artery disease	0.000178	0.000441	CcSEcCtD
Desvenlafaxine—Dermatitis—Niacin—coronary artery disease	0.000178	0.00044	CcSEcCtD
Desvenlafaxine—Dizziness—Enalapril—coronary artery disease	0.000178	0.00044	CcSEcCtD
Desvenlafaxine—Skin disorder—Lisinopril—coronary artery disease	0.000177	0.000439	CcSEcCtD
Desvenlafaxine—Headache—Niacin—coronary artery disease	0.000177	0.000438	CcSEcCtD
Desvenlafaxine—Paraesthesia—Timolol—coronary artery disease	0.000177	0.000438	CcSEcCtD
Desvenlafaxine—Vomiting—Pravastatin—coronary artery disease	0.000177	0.000438	CcSEcCtD
Desvenlafaxine—Hyperhidrosis—Lisinopril—coronary artery disease	0.000176	0.000437	CcSEcCtD
Desvenlafaxine—Diarrhoea—Captopril—coronary artery disease	0.000176	0.000437	CcSEcCtD
Desvenlafaxine—Dizziness—Telmisartan—coronary artery disease	0.000175	0.000434	CcSEcCtD
Desvenlafaxine—SLC6A2—NRF2 pathway—GGT1—coronary artery disease	0.000175	0.00311	CbGpPWpGaD
Desvenlafaxine—Rash—Pravastatin—coronary artery disease	0.000175	0.000434	CcSEcCtD
Desvenlafaxine—Dermatitis—Pravastatin—coronary artery disease	0.000175	0.000434	CcSEcCtD
Desvenlafaxine—Decreased appetite—Ramipril—coronary artery disease	0.000175	0.000434	CcSEcCtD
Desvenlafaxine—Somnolence—Timolol—coronary artery disease	0.000175	0.000433	CcSEcCtD
Desvenlafaxine—Asthenia—Furosemide—coronary artery disease	0.000174	0.000433	CcSEcCtD
Desvenlafaxine—Headache—Pravastatin—coronary artery disease	0.000174	0.000431	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Ramipril—coronary artery disease	0.000174	0.000431	CcSEcCtD
Desvenlafaxine—Fatigue—Ramipril—coronary artery disease	0.000173	0.00043	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Losartan—coronary artery disease	0.000173	0.000429	CcSEcCtD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—ADIPOQ—coronary artery disease	0.000172	0.00306	CbGpPWpGaD
Desvenlafaxine—Nausea—Valsartan—coronary artery disease	0.000172	0.000427	CcSEcCtD
Desvenlafaxine—Constipation—Ramipril—coronary artery disease	0.000172	0.000426	CcSEcCtD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—PPARGC1A—coronary artery disease	0.000172	0.00305	CbGpPWpGaD
Desvenlafaxine—Nausea—Olmesartan—coronary artery disease	0.000171	0.000425	CcSEcCtD
Desvenlafaxine—Vomiting—Trandolapril—coronary artery disease	0.000171	0.000425	CcSEcCtD
Desvenlafaxine—Diarrhoea—Perindopril—coronary artery disease	0.000171	0.000424	CcSEcCtD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—CFTR—coronary artery disease	0.000171	0.00304	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—ATP1A1—coronary artery disease	0.000171	0.00304	CbGpPWpGaD
Desvenlafaxine—Decreased appetite—Timolol—coronary artery disease	0.000171	0.000424	CcSEcCtD
Desvenlafaxine—Vomiting—Enalapril—coronary artery disease	0.000171	0.000423	CcSEcCtD
Desvenlafaxine—Dizziness—Captopril—coronary artery disease	0.00017	0.000422	CcSEcCtD
Desvenlafaxine—Rash—Trandolapril—coronary artery disease	0.00017	0.000422	CcSEcCtD
Desvenlafaxine—Dermatitis—Trandolapril—coronary artery disease	0.00017	0.000421	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Timolol—coronary artery disease	0.00017	0.000421	CcSEcCtD
Desvenlafaxine—Fatigue—Timolol—coronary artery disease	0.00017	0.00042	CcSEcCtD
Desvenlafaxine—Rash—Enalapril—coronary artery disease	0.000169	0.00042	CcSEcCtD
Desvenlafaxine—Dermatitis—Enalapril—coronary artery disease	0.000169	0.000419	CcSEcCtD
Desvenlafaxine—Headache—Trandolapril—coronary artery disease	0.000169	0.000419	CcSEcCtD
Desvenlafaxine—Vomiting—Telmisartan—coronary artery disease	0.000168	0.000418	CcSEcCtD
Desvenlafaxine—Asthenia—Losartan—coronary artery disease	0.000168	0.000417	CcSEcCtD
Desvenlafaxine—Headache—Enalapril—coronary artery disease	0.000168	0.000417	CcSEcCtD
Desvenlafaxine—SLC6A4—NRF2 pathway—HGF—coronary artery disease	0.000168	0.00299	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—GSTM1—coronary artery disease	0.000168	0.00299	CbGpPWpGaD
Desvenlafaxine—Nausea—Niacin—coronary artery disease	0.000167	0.000415	CcSEcCtD
Desvenlafaxine—Rash—Telmisartan—coronary artery disease	0.000167	0.000414	CcSEcCtD
Desvenlafaxine—Dermatitis—Telmisartan—coronary artery disease	0.000167	0.000414	CcSEcCtD
Desvenlafaxine—Diarrhoea—Furosemide—coronary artery disease	0.000166	0.000412	CcSEcCtD
Desvenlafaxine—Headache—Telmisartan—coronary artery disease	0.000166	0.000411	CcSEcCtD
Desvenlafaxine—Dizziness—Perindopril—coronary artery disease	0.000165	0.00041	CcSEcCtD
Desvenlafaxine—Insomnia—Lisinopril—coronary artery disease	0.000165	0.000409	CcSEcCtD
Desvenlafaxine—Nausea—Pravastatin—coronary artery disease	0.000165	0.000409	CcSEcCtD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—HTR7—coronary artery disease	0.000164	0.00292	CbGpPWpGaD
Desvenlafaxine—Paraesthesia—Lisinopril—coronary artery disease	0.000164	0.000406	CcSEcCtD
Desvenlafaxine—Vomiting—Captopril—coronary artery disease	0.000164	0.000406	CcSEcCtD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC6A6—coronary artery disease	0.000163	0.0029	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Tryptophan metabolism—ALDH2—coronary artery disease	0.000163	0.0029	CbGpPWpGaD
Desvenlafaxine—Rash—Captopril—coronary artery disease	0.000162	0.000403	CcSEcCtD
Desvenlafaxine—Dermatitis—Captopril—coronary artery disease	0.000162	0.000402	CcSEcCtD
Desvenlafaxine—Somnolence—Lisinopril—coronary artery disease	0.000162	0.000402	CcSEcCtD
Desvenlafaxine—SLC6A4—NRF2 pathway—AGER—coronary artery disease	0.000162	0.00288	CbGpPWpGaD
Desvenlafaxine—Headache—Captopril—coronary artery disease	0.000161	0.0004	CcSEcCtD
Desvenlafaxine—Dizziness—Furosemide—coronary artery disease	0.000161	0.000399	CcSEcCtD
Desvenlafaxine—Diarrhoea—Losartan—coronary artery disease	0.00016	0.000398	CcSEcCtD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—IL1A—coronary artery disease	0.00016	0.00285	CbGpPWpGaD
Desvenlafaxine—Nausea—Trandolapril—coronary artery disease	0.00016	0.000397	CcSEcCtD
Desvenlafaxine—Nausea—Enalapril—coronary artery disease	0.00016	0.000396	CcSEcCtD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—IL10—coronary artery disease	0.000159	0.00283	CbGpPWpGaD
Desvenlafaxine—Vomiting—Perindopril—coronary artery disease	0.000159	0.000394	CcSEcCtD
Desvenlafaxine—Decreased appetite—Lisinopril—coronary artery disease	0.000159	0.000393	CcSEcCtD
Desvenlafaxine—Rash—Perindopril—coronary artery disease	0.000158	0.000391	CcSEcCtD
Desvenlafaxine—Dermatitis—Perindopril—coronary artery disease	0.000158	0.000391	CcSEcCtD
Desvenlafaxine—Gastrointestinal disorder—Lisinopril—coronary artery disease	0.000157	0.00039	CcSEcCtD
Desvenlafaxine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—coronary artery disease	0.000157	0.0028	CbGpPWpGaD
Desvenlafaxine—Nausea—Telmisartan—coronary artery disease	0.000157	0.00039	CcSEcCtD
Desvenlafaxine—SLC6A2—NRF2 pathway—TGFBR2—coronary artery disease	0.000157	0.0028	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—GSTP1—coronary artery disease	0.000157	0.0028	CbGpPWpGaD
Desvenlafaxine—Fatigue—Lisinopril—coronary artery disease	0.000157	0.00039	CcSEcCtD
Desvenlafaxine—Headache—Perindopril—coronary artery disease	0.000157	0.000388	CcSEcCtD
Desvenlafaxine—Constipation—Lisinopril—coronary artery disease	0.000156	0.000387	CcSEcCtD
Desvenlafaxine—SLC6A2—NRF2 pathway—HMOX1—coronary artery disease	0.000155	0.00276	CbGpPWpGaD
Desvenlafaxine—Dizziness—Losartan—coronary artery disease	0.000155	0.000385	CcSEcCtD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—MEF2C—coronary artery disease	0.000155	0.00276	CbGpPWpGaD
Desvenlafaxine—Vomiting—Furosemide—coronary artery disease	0.000155	0.000383	CcSEcCtD
Desvenlafaxine—Rash—Furosemide—coronary artery disease	0.000153	0.00038	CcSEcCtD
Desvenlafaxine—Dermatitis—Furosemide—coronary artery disease	0.000153	0.00038	CcSEcCtD
Desvenlafaxine—Nausea—Captopril—coronary artery disease	0.000153	0.000379	CcSEcCtD
Desvenlafaxine—Headache—Furosemide—coronary artery disease	0.000152	0.000378	CcSEcCtD
Desvenlafaxine—CYP3A4—Phase 1 - Functionalization of compounds—CYP11B2—coronary artery disease	0.000149	0.00265	CbGpPWpGaD
Desvenlafaxine—Vomiting—Losartan—coronary artery disease	0.000149	0.00037	CcSEcCtD
Desvenlafaxine—Nausea—Perindopril—coronary artery disease	0.000149	0.000368	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Ramipril—coronary artery disease	0.000148	0.000367	CcSEcCtD
Desvenlafaxine—Rash—Losartan—coronary artery disease	0.000148	0.000367	CcSEcCtD
Desvenlafaxine—Dermatitis—Losartan—coronary artery disease	0.000148	0.000366	CcSEcCtD
Desvenlafaxine—Headache—Losartan—coronary artery disease	0.000147	0.000364	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Timolol—coronary artery disease	0.000145	0.000359	CcSEcCtD
Desvenlafaxine—SLC6A2—NRF2 pathway—HGF—coronary artery disease	0.000145	0.00257	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—GSTM1—coronary artery disease	0.000145	0.00257	CbGpPWpGaD
Desvenlafaxine—Nausea—Furosemide—coronary artery disease	0.000144	0.000358	CcSEcCtD
Desvenlafaxine—Asthenia—Ramipril—coronary artery disease	0.000144	0.000358	CcSEcCtD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC9A1—coronary artery disease	0.000143	0.00254	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—SULT4A1—coronary artery disease	0.000143	0.00253	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—coronary artery disease	0.000142	0.00253	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—HTR2A—coronary artery disease	0.000141	0.00251	CbGpPWpGaD
Desvenlafaxine—Asthenia—Timolol—coronary artery disease	0.000141	0.00035	CcSEcCtD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—SULT4A1—coronary artery disease	0.000141	0.0025	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—PPARGC1A—coronary artery disease	0.00014	0.00249	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—AGER—coronary artery disease	0.000139	0.00248	CbGpPWpGaD
Desvenlafaxine—Nausea—Losartan—coronary artery disease	0.000139	0.000345	CcSEcCtD
Desvenlafaxine—Diarrhoea—Ramipril—coronary artery disease	0.000138	0.000341	CcSEcCtD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—COX5B—coronary artery disease	0.000137	0.00243	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—RYR2—coronary artery disease	0.000137	0.00243	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—SIRT1—coronary artery disease	0.000136	0.00241	CbGpPWpGaD
Desvenlafaxine—Diarrhoea—Timolol—coronary artery disease	0.000135	0.000334	CcSEcCtD
Desvenlafaxine—Hypersensitivity—Lisinopril—coronary artery disease	0.000134	0.000333	CcSEcCtD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—HIF1A—coronary artery disease	0.000134	0.00239	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—PLN—coronary artery disease	0.000133	0.00236	CbGpPWpGaD
Desvenlafaxine—Dizziness—Ramipril—coronary artery disease	0.000133	0.00033	CcSEcCtD
Desvenlafaxine—Asthenia—Lisinopril—coronary artery disease	0.000131	0.000325	CcSEcCtD
Desvenlafaxine—Dizziness—Timolol—coronary artery disease	0.00013	0.000322	CcSEcCtD
Desvenlafaxine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C19—coronary artery disease	0.000128	0.00228	CbGpPWpGaD
Desvenlafaxine—Vomiting—Ramipril—coronary artery disease	0.000128	0.000317	CcSEcCtD
Desvenlafaxine—Rash—Ramipril—coronary artery disease	0.000127	0.000314	CcSEcCtD
Desvenlafaxine—CYP3A4—Oxidation by Cytochrome P450—CYP2C19—coronary artery disease	0.000127	0.00225	CbGpPWpGaD
Desvenlafaxine—Dermatitis—Ramipril—coronary artery disease	0.000127	0.000314	CcSEcCtD
Desvenlafaxine—Headache—Ramipril—coronary artery disease	0.000126	0.000312	CcSEcCtD
Desvenlafaxine—Vomiting—Timolol—coronary artery disease	0.000125	0.00031	CcSEcCtD
Desvenlafaxine—Diarrhoea—Lisinopril—coronary artery disease	0.000125	0.000309	CcSEcCtD
Desvenlafaxine—Rash—Timolol—coronary artery disease	0.000124	0.000307	CcSEcCtD
Desvenlafaxine—Dermatitis—Timolol—coronary artery disease	0.000124	0.000307	CcSEcCtD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—HK2—coronary artery disease	0.000124	0.0022	CbGpPWpGaD
Desvenlafaxine—Headache—Timolol—coronary artery disease	0.000123	0.000305	CcSEcCtD
Desvenlafaxine—Dizziness—Lisinopril—coronary artery disease	0.000121	0.000299	CcSEcCtD
Desvenlafaxine—Nausea—Ramipril—coronary artery disease	0.000119	0.000296	CcSEcCtD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—ATP4A—coronary artery disease	0.000119	0.00211	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC27A1—coronary artery disease	0.000119	0.00211	CbGpPWpGaD
Desvenlafaxine—Nausea—Timolol—coronary artery disease	0.000117	0.00029	CcSEcCtD
Desvenlafaxine—Vomiting—Lisinopril—coronary artery disease	0.000116	0.000288	CcSEcCtD
Desvenlafaxine—Rash—Lisinopril—coronary artery disease	0.000115	0.000285	CcSEcCtD
Desvenlafaxine—Dermatitis—Lisinopril—coronary artery disease	0.000115	0.000285	CcSEcCtD
Desvenlafaxine—Headache—Lisinopril—coronary artery disease	0.000114	0.000283	CcSEcCtD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—CREB1—coronary artery disease	0.000113	0.002	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—IL6R—coronary artery disease	0.00011	0.00195	CbGpPWpGaD
Desvenlafaxine—Nausea—Lisinopril—coronary artery disease	0.000108	0.000269	CcSEcCtD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—LEP—coronary artery disease	0.000107	0.0019	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—coronary artery disease	0.000107	0.0019	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—ATP2B1—coronary artery disease	0.000105	0.00187	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC22A3—coronary artery disease	0.000105	0.00187	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Tryptophan metabolism—CAT—coronary artery disease	0.000105	0.00186	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C19—coronary artery disease	0.000104	0.00185	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—GSTM2—coronary artery disease	0.000102	0.00181	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—GSTM2—coronary artery disease	0.0001	0.00178	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—NOS2—coronary artery disease	9.98e-05	0.00177	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—HK1—coronary artery disease	9.7e-05	0.00172	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—ABCG5—coronary artery disease	9.7e-05	0.00172	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC8A1—coronary artery disease	9.7e-05	0.00172	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—SULT1E1—coronary artery disease	9.63e-05	0.00171	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—SULT1E1—coronary artery disease	9.5e-05	0.00169	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—PPARG—coronary artery disease	9.33e-05	0.00166	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—GSK3B—coronary artery disease	9.27e-05	0.00165	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—CREB1—coronary artery disease	9.2e-05	0.00164	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—AKR1B1—coronary artery disease	9.06e-05	0.00161	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—coronary artery disease	9.02e-05	0.0016	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—CXCL8—coronary artery disease	8.72e-05	0.00155	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—SERPINE1—coronary artery disease	8.4e-05	0.00149	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—IL1B—coronary artery disease	8.36e-05	0.00149	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—CASP3—coronary artery disease	8.34e-05	0.00148	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—GCLM—coronary artery disease	8.19e-05	0.00146	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—CYP11B2—coronary artery disease	7.93e-05	0.00141	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—CYP11B2—coronary artery disease	7.82e-05	0.00139	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—ATP2A2—coronary artery disease	7.45e-05	0.00132	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC9A1—coronary artery disease	7.27e-05	0.00129	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—SULT1A1—coronary artery disease	7.21e-05	0.00128	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—GPX2—coronary artery disease	7.2e-05	0.00128	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—CETP—coronary artery disease	7.18e-05	0.00128	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—GPX4—coronary artery disease	7.11e-05	0.00126	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—SULT1A1—coronary artery disease	7.11e-05	0.00126	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—VEGFA—coronary artery disease	7.08e-05	0.00126	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—GSTA1—coronary artery disease	7.04e-05	0.00125	CbGpPWpGaD
Desvenlafaxine—SLC6A4—NRF2 pathway—TGFB1—coronary artery disease	6.85e-05	0.00122	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—TFRC—coronary artery disease	6.81e-05	0.00121	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—PLAT—coronary artery disease	6.33e-05	0.00113	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—TNF—coronary artery disease	6.07e-05	0.00108	CbGpPWpGaD
Desvenlafaxine—SLC6A2—NRF2 pathway—TGFB1—coronary artery disease	5.89e-05	0.00105	CbGpPWpGaD
Desvenlafaxine—SLC6A2—SLC-mediated transmembrane transport—ALB—coronary artery disease	5.87e-05	0.00104	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—GPX3—coronary artery disease	5.84e-05	0.00104	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—ALDH2—coronary artery disease	5.68e-05	0.00101	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—coronary artery disease	5.65e-05	0.001	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—CYP2C19—coronary artery disease	5.53e-05	0.000983	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—CYP2C19—coronary artery disease	5.46e-05	0.00097	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—GSTT1—coronary artery disease	5.4e-05	0.00096	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—PLG—coronary artery disease	5.38e-05	0.000957	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—GCLC—coronary artery disease	5.34e-05	0.000949	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—HMOX1—coronary artery disease	4.97e-05	0.000883	CbGpPWpGaD
Desvenlafaxine—SLC6A4—SIDS Susceptibility Pathways—IL6—coronary artery disease	4.9e-05	0.00087	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—APOB—coronary artery disease	4.76e-05	0.000846	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—coronary artery disease	4.58e-05	0.000813	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—GGT1—coronary artery disease	4.17e-05	0.000741	CbGpPWpGaD
Desvenlafaxine—SLC6A4—Circadian rythm related genes—IL6—coronary artery disease	4e-05	0.000711	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CA5B—coronary artery disease	3.78e-05	0.000673	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—APOA1—coronary artery disease	3.77e-05	0.000669	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—GSTP1—coronary artery disease	3.74e-05	0.000665	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—GSTP1—coronary artery disease	3.69e-05	0.000656	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—GSTM1—coronary artery disease	3.44e-05	0.000611	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metapathway biotransformation—GSTM1—coronary artery disease	3.39e-05	0.000603	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CKMT1B—coronary artery disease	3.22e-05	0.000572	CbGpPWpGaD
Desvenlafaxine—SLC6A2—Transmembrane transport of small molecules—ALB—coronary artery disease	2.98e-05	0.00053	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CKM—coronary artery disease	2.62e-05	0.000466	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—UQCRFS1—coronary artery disease	2.62e-05	0.000466	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PPAP2B—coronary artery disease	2.62e-05	0.000466	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—SULT4A1—coronary artery disease	2.44e-05	0.000433	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CKMT2—coronary artery disease	2.44e-05	0.000433	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PDK4—coronary artery disease	2.44e-05	0.000433	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ALDH6A1—coronary artery disease	2.44e-05	0.000433	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PYGM—coronary artery disease	2.44e-05	0.000433	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Biological oxidations—POMC—coronary artery disease	2.43e-05	0.000432	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GK—coronary artery disease	2.17e-05	0.000386	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—LDHA—coronary artery disease	2.17e-05	0.000386	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GYG1—coronary artery disease	2.17e-05	0.000386	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PFKM—coronary artery disease	2.17e-05	0.000386	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—HMGCS2—coronary artery disease	2.17e-05	0.000386	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GATM—coronary artery disease	2.17e-05	0.000386	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—AK1—coronary artery disease	2.07e-05	0.000369	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GCH1—coronary artery disease	2.07e-05	0.000369	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—MDH2—coronary artery disease	1.99e-05	0.000353	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PPAT—coronary artery disease	1.99e-05	0.000353	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PLCD1—coronary artery disease	1.99e-05	0.000353	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—UGCG—coronary artery disease	1.99e-05	0.000353	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PGM1—coronary artery disease	1.91e-05	0.00034	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PYGB—coronary artery disease	1.85e-05	0.000329	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CKB—coronary artery disease	1.85e-05	0.000329	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—DLAT—coronary artery disease	1.74e-05	0.000309	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—COX5B—coronary artery disease	1.74e-05	0.000309	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GSTM2—coronary artery disease	1.74e-05	0.000309	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PFKFB3—coronary artery disease	1.74e-05	0.000309	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PLIN1—coronary artery disease	1.74e-05	0.000309	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—SULT1E1—coronary artery disease	1.65e-05	0.000293	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—AKR1B1—coronary artery disease	1.57e-05	0.000279	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—HK2—coronary artery disease	1.57e-05	0.000279	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—SLC27A1—coronary artery disease	1.51e-05	0.000268	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—LCAT—coronary artery disease	1.48e-05	0.000263	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CPT1B—coronary artery disease	1.48e-05	0.000263	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—APOA4—coronary artery disease	1.45e-05	0.000258	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PDHA1—coronary artery disease	1.4e-05	0.000249	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GCLM—coronary artery disease	1.4e-05	0.000249	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—TXNRD1—coronary artery disease	1.36e-05	0.000241	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CYP11B2—coronary artery disease	1.36e-05	0.000241	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—SLC22A3—coronary artery disease	1.34e-05	0.000238	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—HADH—coronary artery disease	1.32e-05	0.000234	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ARNTL—coronary artery disease	1.32e-05	0.000234	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	1.25e-05	0.000222	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—APOA2—coronary artery disease	1.25e-05	0.000222	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GPX2—coronary artery disease	1.25e-05	0.000222	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—HK1—coronary artery disease	1.23e-05	0.000219	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ABCG5—coronary artery disease	1.23e-05	0.000219	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—SULT1A1—coronary artery disease	1.23e-05	0.000219	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GPX4—coronary artery disease	1.23e-05	0.000219	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—HADHA—coronary artery disease	1.22e-05	0.000217	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GSTA1—coronary artery disease	1.2e-05	0.000214	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—LPA—coronary artery disease	1.19e-05	0.000212	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PLCB3—coronary artery disease	1.15e-05	0.000205	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—APOA5—coronary artery disease	1.14e-05	0.000203	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—P4HB—coronary artery disease	1.12e-05	0.000199	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	1.1e-05	0.000195	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—VCAN—coronary artery disease	1.04e-05	0.000184	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ALDOA—coronary artery disease	1.03e-05	0.000183	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—DCN—coronary artery disease	9.98e-06	0.000177	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ALDH2—coronary artery disease	9.71e-06	0.000173	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—LIPC—coronary artery disease	9.46e-06	0.000168	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—HBA1—coronary artery disease	9.46e-06	0.000168	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	9.46e-06	0.000168	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CYP2C19—coronary artery disease	9.46e-06	0.000168	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—APOC3—coronary artery disease	9.4e-06	0.000167	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—LDLR—coronary artery disease	9.35e-06	0.000166	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GSTT1—coronary artery disease	9.23e-06	0.000164	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—SLC9A1—coronary artery disease	9.23e-06	0.000164	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CETP—coronary artery disease	9.13e-06	0.000162	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GCLC—coronary artery disease	9.13e-06	0.000162	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—SDC1—coronary artery disease	9.03e-06	0.00016	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PSMB5—coronary artery disease	8.53e-06	0.000152	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PSMA6—coronary artery disease	8.53e-06	0.000152	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CTGF—coronary artery disease	8.33e-06	0.000148	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GOT2—coronary artery disease	8.26e-06	0.000147	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—HMGCR—coronary artery disease	8.26e-06	0.000147	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PLCB1—coronary artery disease	7.59e-06	0.000135	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ABCA1—coronary artery disease	7.36e-06	0.000131	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GGT1—coronary artery disease	7.13e-06	0.000127	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GOT1—coronary artery disease	7.13e-06	0.000127	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GSTP1—coronary artery disease	6.4e-06	0.000114	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	6.34e-06	0.000113	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—HMOX1—coronary artery disease	6.31e-06	0.000112	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CAT—coronary artery disease	6.23e-06	0.000111	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—APOB—coronary artery disease	6.05e-06	0.000107	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GSTM1—coronary artery disease	5.88e-06	0.000105	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—LPL—coronary artery disease	5.77e-06	0.000103	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—GPX1—coronary artery disease	5.63e-06	0.0001	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—CD36—coronary artery disease	5.49e-06	9.75e-05	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PPP2CA—coronary artery disease	5.42e-06	9.63e-05	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—MTHFR—coronary artery disease	5.2e-06	9.24e-05	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—AGT—coronary artery disease	4.94e-06	8.78e-05	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—APOE—coronary artery disease	4.84e-06	8.6e-05	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—APOA1—coronary artery disease	4.78e-06	8.5e-05	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PPARG—coronary artery disease	4.22e-06	7.49e-05	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—POMC—coronary artery disease	4.16e-06	7.39e-05	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—ALB—coronary artery disease	3.79e-06	6.74e-05	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—NOS3—coronary artery disease	3.63e-06	6.44e-05	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PTGS2—coronary artery disease	3.32e-06	5.89e-05	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—PIK3CA—coronary artery disease	2.04e-06	3.63e-05	CbGpPWpGaD
Desvenlafaxine—CYP3A4—Metabolism—AKT1—coronary artery disease	1.67e-06	2.96e-05	CbGpPWpGaD
